ALLO
Allogene Therapeutics Inc
Price:  
1.19 
USD
Volume:  
1,384,912.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALLO Fair Value

-584.70 %
Upside

What is the fair value of ALLO?

As of 2025-07-07, the Fair Value of Allogene Therapeutics Inc (ALLO) is -5.77 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.19 USD, the upside of Allogene Therapeutics Inc is -584.70%.

Is ALLO a good investment?

With the market price of 1.19 USD and our fair value calculation, Allogene Therapeutics Inc (ALLO) is not a good investment. Investing in ALLO stocks now will result in a potential loss of 584.70%.

Note: valuation result may not be accurate due to the company's negative EPS.

1.19 USD
Stock Price
-5.77 USD
Fair Price
FAIR VALUE CALCULATION

ALLO Fair Value

Peter Lynch's formula is:

ALLO Fair Value
= Earnings Growth Rate x TTM EPS
ALLO Fair Value
= 5.00 x -1.15
ALLO Fair Value
= -5.77

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -250.22 -257.01 -332.63 -327.26 -257.59 -284.94
YoY growth -35.55% -2.71% -29.42% 1.61% 21.29% -8.96%

ALLO Fair Value - Key Data

Market Cap (mil) 260.29
P/E
Forward P/E
EPS -1.15
Avg earnings growth rate -8.96%
TTM earnings -252.32